Haematology Team - Monthly Report
Representative
Please Select
Lynne Florence
Bernadine Bishop
Lianne Lattimer
Lean de Witt
Report Month
*
Please Select
May 2013
June '13
July '13
August '13
September '13
October '13
November '13
December '13
January '14
February '14
March '14
April '14
May '14
June '14
July '14
August '14
September '14
October '14
November '14
December '14
Snap shot of YTD Performance vs. Target
Click to edit
*
EU TARGET: CYCLE
EU ACTUAL: CYCLE
PERCENTAGE ACHIEVED
MabThera total (private)
Mabthera total (public)
Neulastim
Neupogen
Recormon
Top 5 Declining Practices
No. 1 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
EU units YTD 2013
EU units YTD 2012
Growth vs. Previous Month
MabThera
Neulastim
Neupogen
Recormon
Action Plan
*
No. 2 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
EU units YTD 2013
EU units YTD 2012
Growth vs. Previous Month
MabThera
Neulastim
Neupogen
Recormon
Action Plan/ Comments
*
No. 3 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
EU units YTD 2013
EU units YTD 2012
Growth vs. Previous Month
MabThera
Neulastim
Neupogen
Recormon
Action Plan
*
No. 4 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
EU units YTD 2013
EU units YTD 2012
Growth vs. Previous Month
MabThera
Neulastim
Neupogen
Recormon
Action Plan
*
No. 5 Declining Practice
Customer(s)
*
Action Plan
*
Latest Market Shares and Growth
*
EU units YTD 2013
EU units YTD 2012
Growth vs. Previous Month
MabThera
Neulastim
Neupogen
Recormon
Public Sector
Hospital 1
Hospital Name
*
Actions
*
Pharmacy Called on
Buyer Called on
Infusion sisters seen
Other
MabThera usage & Status
*
Key action plans completed?
*
RESPONSIBLE PERSON
*
Responsible
Sales representative
1
Sales Manager support
2
Product Manager support
3
Market Access
4
NHI Key Accounts
5
Hospital 2
Hospital Name
*
Actions
*
Pharmacy Called on
Buyer Called on
Infusion sisters seen
Other
MabThera usage & Status
*
Key action plans completed?
*
RESPONSIBLE PERSON
*
Responsible
Sales representative
6
Sales Manager support
7
Product Manager support
8
Market Access
9
NHI Key Accounts
10
Hospital 3
Hospital Name
*
Actions
*
Pharmacy Called on
Buyer Called on
Infusion sisters seen
Other
MabThera usage & Status
*
Key action plans completed?
*
RESPONSIBLE PERSON
*
Responsible
Sales representative
11
Sales Manager support
12
Product Manager support
13
Market Access
14
NHI Key Accounts
15
Hospital 4
Hospital Name
*
Actions
*
Pharmacy Called on
Buyer Called on
Infusion sisters seen
Other
MabThera usage & Status
*
Key action plans completed?
*
RESPONSIBLE PERSON
*
Responsible
Sales representative
16
Sales Manager support
17
Product Manager support
18
Market Access
19
NHI Key Accounts
20
Monthly Activities
Activities for the Reported Month
*
Monthly representative Spend
PRODUCT PROMOTION
*
MabThera Spend
Neulastim/ Neupogen Spend
Recormon Spend
Total:
0
/
4250
Competitor Intelligence
Exprex
*
Granocyte
*
Other CI
*
CRM & CHRIS compliance
Roche Systems
*
Completed
Not completed
CHRIS - comments input
21
22
CHRIS - manager discussion
23
24
CRM - synchronisation before 08:00
25
26
Territory Plan Updated
27
28
Signature
*
E-mail
Submit
Should be Empty: